1. Home
  2. AVXL vs BOOM Comparison

AVXL vs BOOM Comparison

Compare AVXL & BOOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$1.26

Market Cap

115.9M

Sector

Health Care

ML Signal

HOLD

Logo DMC Global Inc.

BOOM

DMC Global Inc.

SELL

Current Price

$7.98

Market Cap

109.5M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
AVXL
BOOM
Founded
2004
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Specialties
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
115.9M
109.5M
IPO Year
2013
1995

Fundamental Metrics

Financial Performance
Metric
AVXL
BOOM
Price
$1.26
$7.98
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
★ $8.00
AVG Volume (30 Days)
★ 1.2M
635.3K
Earning Date
11-24-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 89.02
EPS
N/A
★ 0.36
Revenue
N/A
★ $609,840,000.00
Revenue This Year
N/A
$2.69
Revenue Next Year
N/A
$5.90
P/E Ratio
★ N/A
$24.93
Revenue Growth
★ N/A
N/A
52 Week Low
$1.13
$4.69
52 Week High
$7.60
$9.79

Technical Indicators

Market Signals
Indicator
AVXL
BOOM
Relative Strength Index (RSI) 27.79 75.32
Support Level $1.14 $5.17
Resistance Level $1.60 N/A
Average True Range (ATR) 0.10 0.51
MACD 0.02 0.47
Stochastic Oscillator 14.89 80.49

Price Performance

Historical Comparison
AVXL
BOOM

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

About BOOM DMC Global Inc.

DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets. Its business is organized into three segments: Arcadia, DynaEnergetics, and NobelClad. Arcadia Products supplies architectural building products, including exterior and interior framing systems, windows, urtain walls, storefronts etc to the commercial construction market. NobelClad is involved in the production of explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints. DynaEnergetics driver, designs manufactures and distributes products utilized by the oil and gas industry principally for the perforation of oil and gas wells.

Share on Social Networks: